Profil
Andreas Pahl is currently Managing Director at Heidelberg Pharma Research GmbH since 2024.
Former positions include Chief Executive Officer at Heidelberg Pharma AG from 2024 to 2025, Head-Late Pharmacology at Takeda Pharmaceutical Co., Ltd., Professor-Pharmacology & Toxicology at Friedrich-Alexander University of Erlangen-Nuremberg, Professor at Technical University of Berlin, Chief Scientific Officer at Heidelberg Pharma AG, Head-Late Pharmacology at Nycomed GmbH, and Member of the Supervisory Board at Emergence Therapeutics AG.
Education includes undergraduate studies at Humboldt-Universität zu Berlin.
Aktiva positioner av Andreas Pahl
| Företag | Position | Start |
|---|---|---|
Heidelberg Pharma Research GmbH
Heidelberg Pharma Research GmbH Miscellaneous Commercial ServicesCommercial Services Engages in researching biotechnology | Verkställande Direktör | 2024-02-01 |
Tidigare kända positioner av Andreas Pahl
| Företag | Position | Slut |
|---|---|---|
| HEIDELBERG PHARMA AG | Verkställande Direktör | 2025-11-24 |
Nycomed GmbH
Nycomed GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Företagsledare/Principal | - |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Företagsledare/Principal | - |
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel antibody drugs | Direktör/Styrelseledamot | - |
Friedrich-Alexander University of Erlangen-Nuremberg
Friedrich-Alexander University of Erlangen-Nuremberg Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
Andreas Pahls utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
Takeda Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
Heidelberg Pharma AG
Heidelberg Pharma AG Pharmaceuticals: MajorHealth Technology Develops cancer therapies | Health Technology |
Friedrich-Alexander University of Erlangen-Nuremberg
Friedrich-Alexander University of Erlangen-Nuremberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Technical University of Berlin
Technical University of Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Humboldt-Universität zu Berlin
Humboldt-Universität zu Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Heidelberg Pharma AG /Old/
Heidelberg Pharma AG /Old/ Miscellaneous Commercial ServicesCommercial Services Provides drug development services | Commercial Services |
Nycomed GmbH
Nycomed GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Heidelberg Pharma Research GmbH
Heidelberg Pharma Research GmbH Miscellaneous Commercial ServicesCommercial Services Engages in researching biotechnology | Commercial Services |
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel antibody drugs | Health Technology |
















